Skip to main content
OpenTrials
Completed

NCT Number: NCT01047904

Anesthetizing the Tympanic Membrane in Healthy Volunteers

The study will evaluate the performance and reliability of minor design changes to the Acclarent Iontophoresis System components for anesthetizing the tympanic membrane in healthy volunteers. Data collected from this study will enable the development of future applications and technology.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

East Palo Alto, California, 94303, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • >=18 years of age
  • Both male and female subjects are eligible.

Exclusion criteria

  • Pregnant or lactating females
  • Subjects with a history of sensitivity or reaction to lidocaine, epinephrine or any hypersensitivity to local anesthetics of the amide type, or any component of the drug solution.
  • Markedly atrophic TM
  • Perforated TM
  • Sclerotic TM
  • Otitis externa
  • Electrically sensitive subjects and subjects with electrically sensitive support systems (pacemakers, defibrillators, etc.)
  • Damaged or denuded skin in the auditory canal
  • Cerumen impaction resulting in a significant amount of cleaning required to visualize the tympanic membrane
  • Evidence of Otitis Media at day of procedure, or within the past three (3) months prior to procedure.

Treatment and study plan

Acclarent Iontophoresis System

Device

Administration of local anesthesia using the Acclarent Iontophoresis System

Primary outcomes

  1. Procedural Success

    Time frame: X days

    Evaluation of the performance and reliability of the Acclarent Iontophoresis System in delivery of local anesthesia to the TM in healthy volunteers

Secondary outcomes

  1. Incidence of adverse effects associated with the System and the Iontophoresis procedure

    Time frame: X days

    The investigator will rate any adverse event that occurs during the procedure for level of severity and relationship to the study device.

  2. Tolerability of the iontophoresis system

    Time frame: X days

    Subject tolerability of the iontophoresis procedure will be assessed using a pain scale

Sponsors and collaborators

Lead sponsor

Integra LifeSciences Corporation

Industry

Collaborators

  • Acclarent

Registry information

Official study title

Performance and Reliability of the Acclarent Iontophoresis System for Anesthetizing the Tympanic Membrane in Healthy Volunteers

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
Jan 13, 2010
Registry last updated
Jul 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.